Nurix Therapeutics, Inc. Common stock (NASDAQ: NRIX) last traded at $26.72, down 1.22% on the session. The quote above updates while this page is open; the figures below are drawn from Nurix Therapeutics, Inc. Common stock’s own filings and are restated only when a new one is published.
Nurix Therapeutics, Inc. Common stock trades on NASDAQ under the ticker NRIX. Its market capitalisation is $2.77 billion.
Valuation measures for Nurix Therapeutics, Inc. Common stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.77B |
|---|---|
| Enterprise value | $2.84B |
| Price / sales | 75.42 |
| Price / book | 6.89 |
| Beta | 1.49 |
Trailing-twelve-month figures tagged in Nurix Therapeutics, Inc. Common stock's XBRL filings with the SEC.
| Revenue (TTM) | $36.77M |
|---|---|
| Net income (TTM) | -$341.35M |
| EPS (TTM) | -$3.46 |
| Operating margin | -982.37% |
| Return on equity | -84.78% |
| Cash | $67.69M |
Range and volume for NRIX over the past 52 weeks.
| 52-week high | $28.23 |
|---|---|
| 52-week low | $8.20 |
| Volume | 1.49M |
| Average volume | 2.00M |
| Previous close | $27.05 |
Dividend history for Nurix Therapeutics, Inc. Common stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.